the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients

• Conditions: Cholangiocarcinoma

• Registration Number: NCT04415190
• Lead Sponsor: Central Hospital, Nancy, France

Brief Summary

The prognosis for cholangiocarcinoma is bad. Potentially, early management by a palliative care team could increase overall survival. We will also assess whether early management by a palliative care team could impact progression-free survival, the place of death and the date of the last chemotherapy, in particular to avoid unnecessary chemotherapy cures in an imminent end of life

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-05
• Study First Submitted: 2020-05-29
• Study Start: 2020-06-01
• Primary Completion: 2020-06-01
• Study First Submitted QC: 2020-06-02
• Last Update Submitted: 2020-06-02
• Study First Posted: 2020-06-04
• Last Update Posted: 2020-06-04
• Study Completion: 2020-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Age> 18 years old
• intra- or extra-hepatic CCK or histologically proven vesicular adenocarcinoma
• Locally advanced and / or metastatic disease from the start or recurrent
• Initial diagnosis or recurrence between 1/01/2013 and 31/12/2019

Exclusion Criteria

• <18 years old
• death less than one week after the diagnostic

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Global survival	baseline	Global survival from the diagnosis (to the death or because of lost to follow up)

Trial Locations

Locations (1)

Lopez; 🇫🇷 Vandœuvre-lès-Nancy, France